Loading...
XSHG
600380
Market cap3.27bUSD
Dec 05, Last price  
12.64CNY
1D
-0.24%
1Q
-6.30%
Jan 2017
40.60%
IPO
180.27%
Name

Joincare Pharmaceutical Group Industry Co Ltd

Chart & Performance

D1W1MN
XSHG:600380 chart
P/E
16.68
P/S
1.48
EPS
0.76
Div Yield, %
1.42%
Shrs. gr., 5y
-0.71%
Rev. gr., 5y
5.45%
Revenues
15.62b
-6.17%
2,488,918,1192,076,203,6792,498,556,7272,938,487,3603,683,247,0604,472,857,5984,791,513,5305,849,960,9206,219,885,2017,417,906,2358,641,891,3769,721,544,23910,779,258,18711,203,963,98911,980,153,10913,521,605,76815,903,688,26617,142,753,06816,646,350,34915,619,480,000
Net income
1.39b
-3.90%
128,009,0420725,072,4840486,007,539740,046,667261,953,124169,521,951273,624,524354,238,756412,469,700451,415,1992,133,040,434699,410,8551,850,018,0102,578,466,4952,612,849,0382,894,096,0961,442,779,7221,386,570,000
CFO
3.64b
-7.45%
363,129,421272,498,706429,263,438455,013,618605,663,1041,105,268,466650,356,523734,362,616635,518,849979,456,2261,264,582,8331,644,557,2671,870,376,0971,825,535,7992,312,447,6873,024,999,5922,563,089,0453,977,705,1393,928,909,6093,636,320,913
Dividend
Jul 18, 20240.18 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China. The company offers chemical drug preparation products, including respiration, gastroenterology, anti-infection, gonadotropic, and psychiatric products; and traditional chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment, including autoimmunity multiple detection platform and diagnostic kit for IgM; and healthcare products, which includes American ginseng tea and Jingxin menocare essence. In addition, the company engages in the wholesale and retail of skin care products, cosmetics, and other necessities. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China.
IPO date
Jun 08, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT